Literature DB >> 12937272

Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.

Helen C Ardley1, Gina B Scott, Stephen A Rose, Nancy G S Tan, Alexander F Markham, Philip A Robinson.   

Abstract

Association between protein inclusions and neurodegenerative diseases, including Parkinson's and Alzheimer's diseases, and polyglutamine disorders, has been widely documented. Although ubiquitin is conjugated to many of these aggregated proteins, the 26S proteasome does not efficiently degrade them. Mutations in the ubiquitin-protein ligase Parkin are associated with autosomal recessive juvenile Parkinsonism. Although Parkin-positive inclusions are not detected in brains of autosomal recessive juvenile Parkinsonism patients, Parkin is found in Lewy bodies in sporadic disease. This suggests that loss of Parkin ligase activity via mutation, or sequestration to Lewy bodies, is a contributory factor to sporadic disease onset. We now demonstrate that decreased proteasomal activity causes formation of large, noncytotoxic inclusions within the cytoplasm of both neuronal and nonneuronal cells overexpressing Parkin. This is not a general phenomenon as there is an absence of similar inclusions when HHARI, a structural homolog of Parkin, is overexpressed. The inclusions colocalize with ubiquitin and with proteasomes. Furthermore, Parkin inclusions colocalize with gamma-tubulin, acetylated alpha-tubulin, and cause redistribution of vimentin, suggesting aggresome-like properties. Our data imply that lower proteasomal activity, previously observed in brain tissue of Parkinson's disease patients, leads to Parkin accumulation and a concomitant reduction in ligase activity, thereby promoting Lewy body formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937272      PMCID: PMC266771          DOI: 10.1091/mbc.e03-02-0078

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  95 in total

1.  Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis.

Authors:  Y Tanaka; S Engelender; S Igarashi; R K Rao; T Wanner; R E Tanzi; A Sawa; V L Dawson; T M Dawson; C A Ross
Journal:  Hum Mol Genet       Date:  2001-04-15       Impact factor: 6.150

2.  Specificity in intracellular protein aggregation and inclusion body formation.

Authors:  R S Rajan; M E Illing; N F Bence; R R Kopito
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

Review 3.  Implications of protein degradation in aging.

Authors:  S Goto; R Takahashi; A A Kumiyama; Z Radák; T Hayashi; M Takenouchi; R Abe
Journal:  Ann N Y Acad Sci       Date:  2001-04       Impact factor: 5.691

4.  Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.

Authors:  E Martín-Aparicio; A Yamamoto; F Hernández; R Hen; J Avila; J J Lucas
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

5.  Complete genomic screen in Parkinson disease: evidence for multiple genes.

Authors:  W K Scott; M A Nance; R L Watts; J P Hubble; W C Koller; K Lyons; R Pahwa; M B Stern; A Colcher; B C Hiner; J Jankovic; W G Ondo; F H Allen; C G Goetz; G W Small; D Masterman; F Mastaglia; N G Laing; J M Stajich; B Slotterbeck; M W Booze; R C Ribble; E Rampersaud; S G West; R A Gibson; L T Middleton; A D Roses; J L Haines; B L Scott; J M Vance; M A Pericak-Vance
Journal:  JAMA       Date:  2001-11-14       Impact factor: 56.272

6.  Transfected synphilin-1 forms cytoplasmic inclusions in HEK293 cells.

Authors:  C O'Farrell; D D Murphy; L Petrucelli; A B Singleton; J Hussey; M Farrer; J Hardy; D W Dickson; M R Cookson
Journal:  Brain Res Mol Brain Res       Date:  2001-12-16

7.  Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.

Authors:  K K Chung; Y Zhang; K L Lim; Y Tanaka; H Huang; J Gao; C A Ross; V L Dawson; T M Dawson
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

8.  The ubiquitin-conjugating enzymes UbcH7 and UbcH8 interact with RING finger/IBR motif-containing domains of HHARI and H7-AP1.

Authors:  T P Moynihan; H C Ardley; U Nuber; S A Rose; P F Jones; A F Markham; M Scheffner; P A Robinson
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

9.  Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1.

Authors:  A B Meriin; K Mabuchi; V L Gabai; J A Yaglom; A Kazantsev; M Y Sherman
Journal:  J Cell Biol       Date:  2001-05-14       Impact factor: 10.539

10.  Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera.

Authors:  R García-Mata; Z Bebök; E J Sorscher; E S Sztul
Journal:  J Cell Biol       Date:  1999-09-20       Impact factor: 10.539

View more
  42 in total

1.  Misfolded Gβ is recruited to cytoplasmic dynein by Nudel for efficient clearance.

Authors:  Yihan Wan; Zhenye Yang; Jing Guo; Qiangge Zhang; Liyong Zeng; Wei Song; Yue Xiao; Xueliang Zhu
Journal:  Cell Res       Date:  2012-03-20       Impact factor: 25.617

2.  FBS/BSA media concentration determines CCCP's ability to depolarize mitochondria and activate PINK1-PRKN mitophagy.

Authors:  Marc P M Soutar; Liam Kempthorne; Emily Annuario; Christin Luft; Selina Wray; Robin Ketteler; Marthe H R Ludtmann; Hélène Plun-Favreau
Journal:  Autophagy       Date:  2019-05-07       Impact factor: 16.016

Review 3.  The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases.

Authors:  Konstanze F Winklhofer; Jörg Tatzelt; Christian Haass
Journal:  EMBO J       Date:  2008-01-23       Impact factor: 11.598

Review 4.  Aggresome formation and neurodegenerative diseases: therapeutic implications.

Authors:  J A Olzmann; L Li; L S Chin
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 5.  E3 ubiquitin ligases in protein quality control mechanism.

Authors:  Deepak Chhangani; Ajay Prakash Joshi; Amit Mishra
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

6.  Human VPS13A is associated with multiple organelles and influences mitochondrial morphology and lipid droplet motility.

Authors:  Wondwossen M Yeshaw; Marianne van der Zwaag; Francesco Pinto; Liza L Lahaye; Anita Ie Faber; Rubén Gómez-Sánchez; Amalia M Dolga; Conor Poland; Anthony P Monaco; Sven Cd van IJzendoorn; Nicola A Grzeschik; Antonio Velayos-Baeza; Ody Cm Sibon
Journal:  Elife       Date:  2019-02-11       Impact factor: 8.140

Review 7.  Proteasome Biology: Chemistry and Bioengineering Insights.

Authors:  Lucia Račková; Erika Csekes
Journal:  Polymers (Basel)       Date:  2020-12-04       Impact factor: 4.329

8.  Genome-wide RNAi screen and in vivo protein aggregation reporters identify degradation of damaged proteins as an essential hypertonic stress response.

Authors:  Keith P Choe; Kevin Strange
Journal:  Am J Physiol Cell Physiol       Date:  2008-10-01       Impact factor: 4.249

9.  BAG-6 is essential for selective elimination of defective proteasomal substrates.

Authors:  Ryosuke Minami; Atsuko Hayakawa; Hiroki Kagawa; Yuko Yanagi; Hideyoshi Yokosawa; Hiroyuki Kawahara
Journal:  J Cell Biol       Date:  2010-08-16       Impact factor: 10.539

10.  Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function.

Authors:  Kenneth M Rosen; Charbel E-H Moussa; Han-Kyu Lee; Pravir Kumar; Tohru Kitada; Gangjian Qin; Qinghao Fu; Henry W Querfurth
Journal:  J Neurosci Res       Date:  2010-01       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.